Auriga Assumes Coverage on Illumina (ILMN) at Buy; Q1 Results Review: Strong and Steady; Consumables Will Carry the Day
Tweet Send to a Friend
Auriga assumes coverage on Illumina (NASDAQ: ILMN) with a Buy. PT $75.
Auriga analyst says, "ILMN reported 1Q11 revenues of ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Auriga analyst says, "ILMN reported 1Q11 revenues of ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
